HARDISH SINGH: Open Payments
NPI 1144490285 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 27 payments from 14 companies in 2025. Trend: 2023 $964 · 2024 $842 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $45 |
| Alkermes, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Braeburn Inc. | 1 | $31 |
Products named: COBENFY, Jornay PM, VRAYLAR, CAPLYTA, Auvelity, REXULTI, INGREZZA, BRIXADI.
Industry payments across NY — which companies pay providers there.
